The Parquet National Financier, a French judicial institution, began a preliminary probe against the country's pharmaceutical company Sanofi S.A. for alleged market manipulation, CNBC reported on Tuesday, citing a legal source.
According to the source, the investigation was launched in March 2023 on charges linked to Sanofi's possible market manipulation caused by the company's financial reports on the anti-allergy drug Dupixent released at the end of 2017.
The report claims that the company said it was completely unaware of this inquiry.
